Heavy Metal Urine Analysis in 20 Healthy Persons Taking Mineralox
NCT00623675 · Status: SUSPENDED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2009-07-07
Summary
Researchers want to find out if urine heavy metal levels are changed in persons who use Mineralox Basic C™ (Mineralox). Mineralox is a zeolite (clinoptilolite) in combination with Vitamin C. Zeolites are natural supplements (nutraceuticals) that work at the cellular level to remove heavy metals and toxins that are accumulated in every day life safely from the body through the urine. The study doctor will give Mineralox to 20 people in this study to see if it helps with the heavy metal removal from the body.
Conditions
- Healthy
Interventions
- DIETARY_SUPPLEMENT
-
Mineralox C
Mineralox C 2 capsules three times a day.
Sponsors & Collaborators
-
CreoMed, Inc.
lead INDUSTRY
Principal Investigators
-
Joseph V Pergolizzi, MD · NEMA Research, Inc.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-02-29
Countries
- United States
Study Locations
More Related Trials
-
Short-term Impact of Cyplexinol® on Self-reported Joint Pain
NCT04764110 ·Status: COMPLETED ·Phase: NA
-
Systemic Markers of Collagen Metabolism and Vitamin C in Smokers and Non-Smokers With Pelvic Organ Prolapse
NCT01548105 ·Status: COMPLETED
-
Proellex Pharmacokinetics Bridging Study
NCT01067807 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Pharmacokinetic Profile of ALXN2050 Modified Release Prototype Formulations and Immediate Release Reference Tablet in Healthy Adult Participants
NCT05780645 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Bioavailability and Pharmacokinetic Study of TNX-102 2.4 mg and Cyclobenzaprine 5 mg Tablets in Healthy Adults.
NCT01490788 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Parecoxib on Patients With CRPS
NCT01523379 ·Status: NO_LONGER_AVAILABLE
-
Anti-inflammatory Agents and Cholesterol Metabolism
NCT01279395 ·Status: TERMINATED
-
Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules
NCT03443960 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Food Interaction Study of Seville Orange Juice and Colchicine
NCT00960193 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics
NCT02336269 ·Status: UNKNOWN
-
A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain
NCT00662558 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
NCT00674856 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice
NCT00984009 ·Status: COMPLETED ·Phase: PHASE1
-
Parecoxib in Renal Colic
NCT00139646 ·Status: TERMINATED ·Phase: PHASE3
-
Dose-Proportionality and Food Effect Study of TNX-102 SL
NCT04164719 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)
NCT03979989 ·Status: COMPLETED ·Phase: PHASE1
-
Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®
NCT00532012 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients
NCT01743300 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole
NCT05237297 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal
NCT02169804 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Oral Doses of Avenanthramide
NCT06101784 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Regulating Urine pH Levels to Alleviate Chronic Joint Pain
NCT01421160 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans
NCT01280006 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure
NCT00624559 ·Status: COMPLETED ·Phase: PHASE4
-
Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin
NCT00785980 ·Status: COMPLETED ·Phase: PHASE1